Anna Falanga Invites You to 13th ICTHIC!
Anna Falanga, Professor of Hematology at University of Milan-Bicocca, shared on LinkedIn:
”Online registration for 13th ICTHIC is open!
Take advantage of the early registration (deadline: January, 31st, 2026)
Submit your abstract here (deadline: January, 10th, 2026)”
ICTHIC, established in 2001, is a leading biennial conference held in Bergamo that unites global experts to discuss advances and challenges in cancer-associated thrombosis.
The relationship between thrombosis and cancer has long been recognized, but the field has expanded rapidly in recent years.
VTE is a frequent and serious complication in cancer patients, particularly during therapy.
Managing these events is difficult due to the dual risks of recurrence and bleeding, highlighting the importance of optimized treatment approaches.
Don’t miss it!
Stay updated with Hemostasis Today.
-
Jan 25, 2026, 15:57Céline Chapelle Shares Clinical Predictors From the API-CAT Trial
-
Jan 25, 2026, 15:42Francesco Lo Monaco on Heart Disease Starting Quiet While Your Labs Speak First
-
Jan 25, 2026, 15:33Wilfried Dinh: Why Heart Patients Still Have Events Despite ”Optimal” Cardiovascular Therapy
-
Jan 25, 2026, 15:25Muhammad Ibrahim on Efficacy and Safety of Extended DOACs Use in VTE
-
Jan 25, 2026, 15:08Tushar Pandey on Managing Thrombotic Thrombocytopenic Purpura
-
Jan 25, 2026, 14:55Carolina Contreras Cuevas Shares a Nationwide Study on VTE in PAD
-
Jan 25, 2026, 14:40Jeannie Devereaux Links PRP and Physical Therapy
-
Jan 25, 2026, 14:25Heghine Khachatryan on Anticoagulation After AFib Ablation: New Evidence from NEJM
-
Jan 25, 2026, 12:42Lale Tokgözoğlu on Cardiovascular Risk Factors in Women